Antisense Therapeutics Ltd: Change of Company Name
Antisense Therapeutics Ltd: Notification of cessation of securities - ANP
Antisense Therapeutics Ltd: Change of Director's Interest Notice (CG,JG)
Antisense Therapeutics Ltd: Notification regarding unquoted securities - ANP
Antisense Therapeutics Ltd: Antisense completes Unmarketable Parcels facility
Antisense Therapeutics Ltd: Proposed issue of securities - ANP
Antisense Therapeutics Ltd: Change of Director's Interest Notice (JG)
Antisense Therapeutics Ltd: Results of Annual General Meeting
Antisense Therapeutics Ltd: Annual General Meeting Presentation
Antisense Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Antisense Therapeutics Ltd: Change in substantial holding
Antisense Therapeutics Ltd: Notice of Annual General Meeting/Proxy Form
Antisense Therapeutics Ltd: Antisense to participate in upcoming investor conferences
Antisense Therapeutics Ltd: Antisense launches Unmarketable Parcels facility
Antisense Therapeutics Ltd: Change of Director's Interest Notice GP
Antisense Therapeutics Ltd: Publication of final Long COVID data for ATL1102
Antisense Therapeutics Ltd: Positive Data for ATL1102 in Limb Girdle Muscular Dystrophy
Antisense Therapeutics Ltd: Antisense Therapeutics Corporate Presentation
Antisense Therapeutics Ltd: Appendix 4G
Antisense Therapeutics Ltd: Corporate Governance Statement
No Data